Abattis Bioceuticals Corp. Share Price Other OTC
Equities
ATTBF
CA00258G1037
Healthcare Facilities & Services
Sales 2018 | 8.37T 6.14T 5L | Sales 2019 | 4L 3L 2.18Cr | Capitalization | 86.17L 63.19L 53Cr |
---|---|---|---|---|---|
Net income 2018 | -7.8Cr -5.72Cr -477.39Cr | Net income 2019 | -30L -22L -18Cr | EV / Sales 2018 | 5,778 x |
Net cash position 2018 | 90.96L 66.7L 56Cr | Net cash position 2019 | 22.51L 16.51L 14Cr | EV / Sales 2019 | 17.8 x |
P/E ratio 2018 |
-0.57
x | P/E ratio 2019 |
-2.8
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 99.64% |
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | - | 01/19/01 | |
Patrick Mitchell
COO | Chief Operating Officer | - | 01/18/01 |
Jonathan Danieli
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Cedric Wilson
BRD | Director/Board Member | - | 19/18/19 |
Patrick Mitchell
COO | Chief Operating Officer | - | 01/18/01 |
Director of Finance/CFO | - | 01/19/01 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 34Cr | |
+24.69% | 24Cr | |
+10.31% | 22Cr | |
+36.05% | 18Cr | |
+141.20% | 14Cr | |
-28.57% | 12Cr | |
+32.61% | 12Cr | |
-47.02% | 11Cr | |
-.--% | 8.71Cr |